Moretti S.; LANZA, Francesco; Dabusti M.; Tieghi A.; CAMPIONI, Diana; Dominici M.; Castoldi GL, CD123 (Interleukin 3 receptor a chain), «JOURNAL OF BIOLOGICAL REGULATORS & HOMEOSTATIC AGENTS», 2001, 15, pp. 98 - 100 [Scientific article]
LANZA, Francesco; CAMPIONI, Diana; MORETTI S; DOMINICI M; PUNTURIERI M; FOCARILE E; PAULI S; DABUSTI M; TIEGHI A; BACILIERI M; SCAPOLI, Chiara; DE ANGELI C; GALLUCCIO L; CASTOLDI, Gianluigi, CD34+ cell subsets and long-term culture colony-forming cells evaluated on both autologous and normal bone marrow stroma predict long-term hematopoietic engraftment in patients undergoing autologous peripheral blood stem cell transplantation, «EXPERIMENTAL HEMATOLOGY», 2001, 29, pp. 1484 - 1493 [Scientific article]
Basso G; Lanza F; F; Orfao A; Moretti S; Castoldi GL, Clinical and biological significance of CD34 expression in acute leukemia, «JOURNAL OF BIOLOGICAL REGULATORS & HOMEOSTATIC AGENTS», 2001, 15, pp. 68 - 78 [Scientific article]
Bononi M; Lanza F; Da Busti M; Ferrazzi G, Increased Myeloperoxidase Index and Large Unstained Cell Values can Predict the Neutropenia Phase of Cancer Patients Treated With Standard Dose Chemotherapy, «CYTOMETRY», 2001, 46, pp. 92 - 97 [Scientific article]
Braylan R; Orfao A; Borowitz M; Davis B; Castoldi GL; Lanza F, Optimal number of reagents required to evaluate hematolymphoid neoplasias. Results of an International Consensus meeting, «CYTOMETRY», 2001, 46, pp. 23 - 27 [Scientific article]
Lanza F; Healy L; Sutherland, Structural and Functional features of the CD34 antigen: an update, «JOURNAL OF BIOLOGICAL REGULATORS & HOMEOSTATIC AGENTS», 2001, 15, pp. 1 - 13 [Scientific article]
Pagano L; Pulsoni A; Tosti ME; Mele L; Del Poeta G; Lanza F; Masini L; Equitani F; Leone G; Mandeli F, Acute leukemia following a previous malignancy: do acute lymphoid leukemia and acute myeloid leukemia have a common risk factors ?, «HEMATOLOGY JOURNAL», 2000, 1, pp. 329 - 332 [Scientific article]
GALLERANI M.; MANFREDINI, Roberto; DONEGA' F.; LANZA, Francesco; DA BUSTI M.; VIGNA, Giovanni Battista; FELLIN, Renato, Adverse haematological effects of ticlopidine. A report of four cases, «CLINICAL DRUG INVESTIGATION», 2000, 19, pp. 231 - 237 [Scientific article]
Gratwohl A; Passweg J; Baldomero H; Lanza F; Castoldi GL, Hematopoietic stem cell Transplantation in Europe 1998, «ACTA HAEMATOLOGICA», 2000, 1, pp. 333 - 350 [Scientific article]
Dominici M; Luppi M; Campioni D; Lanza F; Torelli U; Castoldi GL, PCR with degenerate primers for highly conserved DNA polymerase gene of the herpes virus family show neither HHV-8 nor a variant in bone marrow stromal cells from multiple myeloma, «INTERNATIONAL JOURNAL OF CANCER», 2000, 86, pp. 76 - 82 [Scientific article]
Lanza F; Dominici M; Govoni M; Moretti S; Campioni D; La Corte R; Latorraca A; Tieghi A; Castagnari B; Trotta F; Castoldi GL, Prolonged remission state of refractory adult onset Still's disease following CD34-selected autologous peripheral blood stem cell transplantation, «BONE MARROW TRANSPLANTATION», 2000, 25, pp. 1307 - 1310 [Scientific article]
de Wynter, E A; Ryder, D; Lanza, F; Nadali, G; Johnsen, H; Denning-Kendall, P; Thing-Mortensen, B; Silvestri, F; Testa, N G, Multicentre European study comparing selection techniques for the isolation of CD34+ cells, «BONE MARROW TRANSPLANTATION», 1999, 23, pp. 1191 - 1196 [Scientific article]
Lanza F; Moretti S; Castagnari B; Castoldi GL., Caratterizzazione degli epitopi del CD34 ed analisi dei recettori per fattori di crescita nelle cellule staminali emopoietiche, in: Atti del Congresso della Società di Medicina Trasfusionale, Roma, Societa Italiana Immunoematologia e Trasfusione Associazione:Italiana Centri Trasfusionali, 1998, pp. 116 - 126 [Chapter or essay]
Lanza F; Latorraca A; Moretti S; Castagnari B; Ferrari L; Castoldi GL, Comparative analysis of different permeabilization methods for the flow cytometry measurement of cytoplasmic MPO and lysozyme in normal and leukemic cells, «CYTOMETRY», 1997, 30, pp. 134 - 144 [Scientific article]
Lanza F; Castoldi GL, Potential clinical applications of rhGM-CSF in acute myeloid leukemia based on its biological activity and receptor modulation, «HAEMATOLOGICA», 1997, 82, pp. 239 - 245 [Scientific article]
